CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced its support for the 14 th annual Rare Disease Day, a global awareness campaign for the more than 300 million people living with a rare disease worldwide.